Helping mothers and babies, from conception to birth
At Ferring, we are committed to helping people become parents and to keeping mothers and babies healthy, from conception to birth. Over one third of our research and development investment goes towards finding innovative treatments in reproductive medicine and maternal health. We are also passionate about making a difference to people’s health and quality of life through our work in gastroenterology and orthopaedics.
Believing in the power of research
Each of us at Ferring contribute to providing innovative solutions to help people live better lives. We devote significant research and development investment to new therapeutics, life cycle management and next generation healthcare solutions.
Join us
At Ferring Pharmaceuticals we highly value an attractive working environment that motivates our employees and stimulates the creative abilities and initiative of both individuals and teams. With over 6,000 employees in 56 countries, we are able to draw upon a large multicultural setting to enrich the work of our staff on all levels.
Helping people live better lives
Ferring Pharmaceuticals is a research-driven, specialty biopharmaceutical group committed to helping people around the world build families and live better lives. Ferring is a leader in reproductive medicine and maternal health, and in specialty areas within gastroenterology and orthopaedics. Ferring has been developing treatments for mothers and babies for over 50 years.
News
-
Chrissy Teigen Launches Fertility Out Loud Campaign to Empower Those with Fertility Challenges to Get the Help they Need
-Teigen alongside RESOLVE: The National Infertility Association and Ferring Pharmaceuticals aim to change and amplify the fertility conversation by launching the Fertility Out Loud campaign during N...
-
Ferring Pharmaceuticals Secures Preferred Access for Orthopaedic & Gastroenterology Treatments Through CVS Health and Aetna Pharmacy Benefit
-Parsippany, NJ – December 18, 2020 – Beginning January 1, 2021, Ferring Pharmaceuticals will gain preferred access through CVS Health and Aetna formularies for EUFLEXXA® (1% sodium hyaluronate) for...
-
Ferring Pharmaceuticals Supports Official Proclamation of November as Clostridioides difficile Infection Awareness Month in States of New Jersey and Minnesota
-CDC defines Clostridioides difficile (C. diff) infection as a significant healthcare burden to patients and physicians, labeling C. diff as a public health threat causing an estimated half a millio...